Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVP Modulation of Sweat Sodium in Runners
NCT02084797Completed
- Sponsor
- Oakland University
- Start
- Jun 2011
- Primary completion
- Oct 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tolvaptan and desmopressin in hyponatremia, hypernatremia and Electrolyte imbalance, sponsored by Oakland University. Primary endpoint: Sweat Sodium Concentration Obtained After the Steady-state Portion of the Trial at 4 weeks. Started Jun 2011; status: completed.
02
Drugs
tolvaptandesmopressin
03
Conditions
hyponatremiahypernatremiaElectrolyte imbalance
Beyond the preview
Go deeper on NCT02084797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084797.